Diabetes
From the Journals
Inflammatory markers may explain COVID-19, diabetes dynamic
Higher levels of markers may signal greater susceptibility to cytokine storm.
Conference Coverage
Drone flight launches first-ever insulin drop
Collaborators navigated legal and logistic hurdles for the 43-km round trip, a year in the making.
Conference Coverage
Use of diabetes technology is lower among black, Hispanic patients
Researchers are trying to identify specific patient and physician factors that might explain the differences so that they can be addressed.
Commentary
Can diabetes be cured?
I disagree with Dr. Unger’s assertion that “diabetes cannot be cured.”
From the Journals
AHA updates management when CAD and T2DM coincide
Applied Evidence
Diabetic retinopathy: The FP’s role in preserving vision
Evaluation and Tx of this debilitating complication falls to the eye specialist, but you play a central role in assessing risk and optimizing...
Conference Coverage
Loss of tear glands linked to suboptimal diabetes control
Loss of the glands could serve as a diabetes biomarker, particularly in underserved areas where A1c testing might not be readily available.
Conference Coverage
Enhanced team-based CVD care found to benefit diabetes patients
PHOENIX, ARIZ. – “This implementation strategy could be scaled up within primary care settings in China and other low to middle income countries...
From the Journals
Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D
Alternatives to liver biopsy are less than ideal for detecting advanced fibrosis in patients with underlying diabetes.
Conference Coverage
Patients with preexisting diabetes benefit less from bariatric surgery
The effect was particularly pronounced over time for patients who received gastric bypass surgery.
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.